[1]Patent:WO2015/104662,2015,A1,.Locationinpatent:Page/Pagecolumn37;38
[2]Patent:US2016/326151,2016,A1,.Locationinpatent:Paragraph0206
[3]BioorganicandMedicinalChemistry,2008,vol.16,#4,p.1966-1982
[4]BioorganicandMedicinalChemistryLetters,2007,vol.17,#11,p.3177-3180
[5]BioorganicandMedicinalChemistry,2004,vol.12,#9,p.2115-2137
[1]BulletindesSocietesChimiquesBelges,1960,vol.69,p.312-322
[1]JournaloftheAmericanChemicalSociety,1985,vol.107,p.1556-1561
[1]Patent:US4243805,1981,A,
[1]CollectionofCzechoslovakChemicalCommunications,1979,vol.44,#7,p.2108-2123
[1]JournalofOrganicChemistry,1992,vol.57,p.5254-5255
[2]Patent:WO2015/104662,2015,A1.Locationinpatent:Page/Pagecolumn37
[3]Patent:US2016/326151,2016,A1.Locationinpatent:Paragraph0204
[4]JournaloftheAmericanChemicalSociety,1948,vol.70,p.439
[5]JournaloftheChemicalSociety,1953,p.3326
[6]CollectionofCzechoslovakChemicalCommunications,1975,vol.40,p.719-737
[7]CollectionofCzechoslovakChemicalCommunications,1979,vol.44,p.2108-2123
[8]JournaloftheChemicalSociety,1960,p.672-676
[9]JournaloftheAmericanChemicalSociety,1996,vol.118,p.4036-4048
[10]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.3177-3180
[1]Patent:WO2005/30213,2005,A1.Locationinpatent:Page/Pagecolumn184-185
[2]Tetrahedron,1959,vol.6,p.315,316
[3]Patent:US2003/207924,2003,A1
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2016/4105,2016,A1Locationinpatent:Paragraph00146
[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1Locationinpatent:Paragraph0622;0623
[3]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24013,2017,A1Locationinpatent:Paragraph0622;0623
[4]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24010,2017,A1Locationinpatent:Paragraph006;007
[5]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23986,2017,A1Locationinpatent:Paragraph0626;0627
[6]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/75701,2016,A1Locationinpatent:Paragraph0805;0806
[7]CurrentPatentAssignee:EISAICOLTD-US2016/347717,2016,A1Locationinpatent:Paragraph0619;0620
[8]Steck;Fletcher[JournaloftheAmericanChemicalSociety,1948,vol.70,p.439]
[9]CurrentPatentAssignee:EISAICOLTD-EP1510516,2005,A1Locationinpatent:Page/Pagecolumn101
[10]CurrentPatentAssignee:MERCK&COINC-WO2009/32123,2009,A2Locationinpatent:Page/Pagecolumn178-179
[11]CurrentPatentAssignee:MERCK&COINC-WO2009/32125,2009,A1Locationinpatent:Page/Pagecolumn118
[12]CurrentPatentAssignee:MERCK&COINC-WO2009/32124,2009,A1Locationinpatent:Page/Pagecolumn193
[13]CurrentPatentAssignee:AMGENINC-WO2006/44860,2006,A2Locationinpatent:Page/Pagecolumn37-38
[14]Venkatraman,Srikanth;Velazquez,Francisco;Gavalas,Stephen;Wu,Wanli;Chen,KevinX.;Nair,AnilkumarG.;Bennett,Frank;Huang,Yuhua;Pinto,Patrick;Jiang,Yueheng;Selyutin,Oleg;Vibulbhan,Bancha;Zeng,Qingbei;Lesburg,Charles;Duca,Jose;Heimark,Larry;Huang,Hsueh-Cheng;Agrawal,Sony;Jiang,Chuan-Kui;Ferrari,Eric;Li,Cheng;Kozlowski,Joseph;Rosenblum,Stuart;Shih,Neng-Yang;GeorgeNjoroge[BioorganicandMedicinalChemistry,2014,vol.22,#1,p.447-458]
[15]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/90380,2016,A1Locationinpatent:Paragraph0806
[1]BulletindesSocietesChimiquesBelges,1960,vol.69,p.312-322
[1]CollectionofCzechoslovakChemicalCommunications,1979,vol.44,p.2108-2123
Title: Isomer selective IR-UV depletion spectroscopy of 4-fluorotoluene-NH3: evidence for π-proton-acceptor and linear hydrogen-bonded complexes.
Journal: Physical chemistry chemical physics : PCCP 20110914
Title: The role of the methyl group in stabilising the weak N-H...pi hydrogen bond in the 4-fluorotoluene-ammonia complex.
Journal: Physical chemistry chemical physics : PCCP 20100107